A Breakthrough Treatment for Ulcerative Colitis

Asana Medical Inc.

Asana Medical Inc. is focused on providing physicians with the first-in-class non-pharmacological, non-surgical treatment option for patients suffering from gastrointestinal (GI) diseases, including Ulcerative Colitis, Crohns disease, and Rectal Mucositis. Asana’s device, derived from Extracellular Matrix, will set into motion a paradigm shift in the treatment of Inflammatory Bowel Disease (IBD) and other diseases from symptom-based, anti-inflammatory therapies to providing a protective coating to promote tissue healing.

We are a GI-oriented company of highly motivated innovators, doctors, scientists, engineers, entrepreneurs, and professionals that identified an opportunity to apply existing Tissue Engineering Technology in a novel application. This will spark a change in the treatment of IBD and other GI diseases.


5/18/2016 Asana Medical, Inc. Adds Dr. Hal K. Wrigley to Board of Directors

MIAMI LAKES, FL – May 18, 2016 – Asana Medical, Inc., (“Asana,” the “Company”), an emerging life science company focused […]

5/10/2016 Asana Medical, Inc. Announces Closing of $1.2 Million Convertible Promissory Note Offering

MIAMI LAKES, FL – May 10, 2016 – Asana Medical, Inc. (“Asana,” the “Company”) is pleased to announce that it […]

3/2/2016 Asana Medical, Inc. Names Dr. Christine V. Sapan CEO, Adds University of Miami’s Sergio M. Gonzalez to its Board of Directors

MIAMI LAKES, FL – March 2, 2016 – Asana Medical, Inc., (“Asana,” the “Company”), an emerging life science company focused […]

More News →

Facebook Twitter LinkedIn
Asana Medical Inc.
6135 NW 167 Street, Suite E15
Miami Lakes, FL 33015
tel: (844) 432-7262